These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 4910027)

  • 21. S100P calcium-binding protein expression is associated with high-risk proliferative lesions of the breast.
    Schor AP; Carvalho FM; Kemp C; Silva ID; Russo J
    Oncol Rep; 2006 Jan; 15(1):3-6. PubMed ID: 16328027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of ornithine decarboxylase and polyamines in human breast cancer: correlation with clinicopathologic parameters.
    Cañizares F; Salinas J; de las Heras M; Diaz J; Tovar I; Martinez P; Peñafiel R
    Clin Cancer Res; 1999 Aug; 5(8):2035-41. PubMed ID: 10473083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lobular carcinoma of the breast. Light and electron microscopic and histochemical observations.
    Inaba H; Hizawa K
    Tokushima J Exp Med; 1979 Dec; 26(3-4):105-13. PubMed ID: 545751
    [No Abstract]   [Full Text] [Related]  

  • 24. Nonpalpable carcinoma in fibrocystic disease of the breast.
    Schwartz AM; Siegelman SS
    Surg Gynecol Obstet; 1968 Jan; 126(1):94-8. PubMed ID: 5634614
    [No Abstract]   [Full Text] [Related]  

  • 25. Analysis of the immunohistochemical expression of mammaglobin A in primary breast carcinoma and lymph node metastasis.
    Raica M; Cîmpean AM; Meche A; Alexa A; Suciu C; Mureşan A
    Rom J Morphol Embryol; 2009; 50(3):341-7. PubMed ID: 19690758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A matrix attachment region (MAR)-binding activity due to a p114 kilodalton protein is found only in human breast carcinomas and not in normal and benign breast disease tissues.
    Yanagisawa J; Ando J; Nakayama J; Kohwi Y; Kohwi-Shigematsu T
    Cancer Res; 1996 Feb; 56(3):457-62. PubMed ID: 8564952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [On the relationships between fibro-cystic mastopathy and mammary carcinoma].
    Merighi L; Billi C; Biso F
    Atti Accad Fisiocrit Siena Med Fis; 1968; 17(1):483-501. PubMed ID: 5759181
    [No Abstract]   [Full Text] [Related]  

  • 28. Androgen conjugates in human breast cyst fluids.
    Miller WR; Roberts MM; Creel RJ; Yap PL; Kelly RW; Forrest AP
    J Natl Cancer Inst; 1982 Nov; 69(5):1055-8. PubMed ID: 6215521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
    Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
    Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Fibrocystic mastopathy and cytology of the mammary secretion].
    Volpe A; Guglielmi A; Amoroso L
    G Ital Chir; 1968 Jan; 24(1):85-96. PubMed ID: 5742965
    [No Abstract]   [Full Text] [Related]  

  • 31. Protein catabolism and acid phosphatase activity in mixed normal and neoplastic human cell cultures.
    Miedema E
    J Natl Cancer Inst; 1969 Jan; 42(1):135-8. PubMed ID: 5765224
    [No Abstract]   [Full Text] [Related]  

  • 32. S100P calcium-binding protein overexpression is associated with immortalization of human breast epithelial cells in vitro and early stages of breast cancer development in vivo.
    Guerreiro Da Silva ID; Hu YF; Russo IH; Ao X; Salicioni AM; Yang X; Russo J
    Int J Oncol; 2000 Feb; 16(2):231-40. PubMed ID: 10639564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative expression of the LINE-1 p40 protein in human breast carcinomas and normal breast tissues.
    Asch HL; Eliacin E; Fanning TG; Connolly JL; Bratthauer G; Asch BB
    Oncol Res; 1996; 8(6):239-47. PubMed ID: 8895199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis and treatment of mastopathy.
    Márton Z; Gáti I; Doszpod J; Preisz J; Kecskés L
    Acta Chir Acad Sci Hung; 1969; 10(1):93-103. PubMed ID: 4240634
    [No Abstract]   [Full Text] [Related]  

  • 35. Expression and localization of homeodomain proteins DLX4/HB9 in normal and malignant human breast tissues.
    Neufing PJ; Kalionis B; Horsfall DJ; Ricciardelli C; Stahl J; Vivekanandan S; Raymond W; Tilley WD
    Anticancer Res; 2003; 23(2B):1479-88. PubMed ID: 12820413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N-myc protein expression in human breast carcinoma: prognostic implications.
    Mizukami Y; Nonomura A; Takizawa T; Noguchi M; Michigishi T; Nakamura S; Ishizaki T
    Anticancer Res; 1995; 15(6B):2899-905. PubMed ID: 8669886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The challenge of apocrine proliferations of the breast: a morphologic approach.
    Masood S; Rosa M
    Pathol Res Pract; 2009; 205(3):155-64. PubMed ID: 19147303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survivin, a member of the inhibitors of apoptosis family, is down-regulated in breast carcinoma effusions.
    Kleinberg L; Flørenes VA; Nesland JM; Davidson B
    Am J Clin Pathol; 2007 Sep; 128(3):389-97. PubMed ID: 17709312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Immunocytochemical study of the myoepithelial cells in fibrocystic disease and ductal carcinoma of the breast].
    Karelina TV; Ermilova VD; Rukosuev VS; Kazantseva IA
    Arkh Patol; 1982; 44(12):29-35. PubMed ID: 6299249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of survivin and its clinicopathological correlations in invasive ductal carcinoma of the breast.
    Al-Joudi FS; Iskandar ZA; Hasnan J; Rusli J; Kamal Y; Imran AK; Ahmed M; Zakaria J
    Singapore Med J; 2007 Jul; 48(7):607-14. PubMed ID: 17609820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.